By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ErgoMed, Inc. 

San Antonio  Texas    U.S.A.
Phone: 800-333-ERGO Fax: 210-366-1075



Company News
ErgoMed 2015 Business Update 2/1/2016 9:29:27 AM
ErgoMed Announces Board Changes 1/11/2016 9:39:09 AM
ErgoMed Provides Update On Co-Development Partnerships 12/16/2015 9:31:37 AM
Dilaforette And ErgoMed Initiate Phase II Clinical Trial With Dilaforette’s Sevuparin In Sickle-Cell Disease 10/13/2015 10:39:59 AM
ErgoMed Increases Its Co-Development Contribution Up To $12,000,000 In CEL-SCI (CVM)’s Phase III Head And Neck Cancer Trial 10/5/2015 8:22:49 AM
ErgoMed: Unaudited Interim Results For The Six Months Ended 30 June 2015 9/29/2015 9:17:10 AM
Secondary Placing Of Ordinary Shares In ErgoMed 7/20/2015 11:23:40 AM
ErgoMed’s Co-Development Partner Ferrer Initiates Phase IIa Study Of Lorediplon In Patients With Insomnia 7/14/2015 9:06:58 AM
ErgoMed Strengthens Management Team & Board 7/2/2015 8:51:06 AM
ErgoMed’s Co-Development Partner AEterna Zentaris (AEZS) Completes Patient Recruitment For Zoptec Phase 3 Study With Zoptarelin Doxorubicin In Advanced Endometrial Cancer 6/30/2015 9:56:46 AM